Enliven Therapeutics shares owned by Logos Global Management
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Logos Global Management
from 13F filings
Historical chart of Logos Global Management investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by Logos Global Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by Logos Global Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $4.2M | 307k | 13.84 |
| 2023-09-30 | $4.2M | 307k | 13.66 |
| 2023-06-30 | $6.3M | 307k | 20.41 |
| 2023-03-31 | $8.8M | 401k | 21.90 |